P450 enzymes in steroid processing

Cytochrome P450: Structure, Mechanism, and Biochemistry, Fourth Edition

Volumn , Issue , 2015, Pages 851-879

  Auchus, Richard J ^a   Miller, Walter L ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945152306     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-12108-6_12     Document Type: Chapter

References (210)

1. Klingenberg M (1958) Pigments of rat liver microsomes Arch Biochem Biophys 75:376-386
2. Omura T, Sato R (1964) A new cytochrome in liver microsomes J Biol Chem 239:1375-1376
3. Cooper DY, Levin S, Narasimhulu S, Rosenthal O, Estabrook RW (1965) Photochemical action spectrum of the terminal oxidase of mixed function oxidase systems Science 147:400-402
4. Halkerston IDK, Eickhorn J, Hechter O (1961) A requirement for reduced triphosphopyridine nucleotide for cholesterol side-chain cleavage by mitochondrial fractions of bovine adrenal cortex J Biol Chem 236:374
5. Simpson ER, Boyd GS (1966) The cholesterol sidechain cleavage system of the adrenal cortex: a mixedfunction oxidase Biochem Biophys Res Commun 24:10-17
6. Simpson ER, Boyd GS (1967) The cholesterol sidechain cleavage system of bovine adrenal cortex Eur J Biochem 2:275-285
7. Ryan KJ (1959) Biological aromatization of steroids J Biol Chem 234:268-272
8. 17,20- lyase) associated with one protein Biochemistry 20:4037-4042
9. 17,20 lyase) J Biol Chem 256:3871-3876
10. 17,20 lyase cytochrome P450 J Biol Chem 259:3971-3976
11. Miller WL (1988) Molecular biology of steroid hormone synthesis Endocr Rev 9:295-318
12. Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders Endocr Rev 32:81-151
13. Miller WL (2005) Regulation of steroidogenesis by electron transfer Endocrinology 146:2544-2550
14. Gomes LG, Huang N, Agrawal V, Mendonça BB, Bachega TA, Miller WL (2009) Extra-adrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab 94:89-95
15. Khan N, Sharma KK, Andersson S, Auchus RJ (2004) Human 17β-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells Arch Biochem Biophys 429:50-59
16. Mizrachi D, Auchus RJ (2009) Androgens, estrogens, and hydroxysteroid dehydrogenases Mol Cell Endocrinol 301:37-42
17. Strott CA (2002) Steroid sulfotransferases Endocr Rev 23:703-732
18. Bose H, Lingappa VR, Miller WL (2002) Rapid regulation of steroidogenesis by mitochondrial protein import Nature 417:87-91
19. Clark BJ, Wells J, King SR, Stocco DM (1994) The purification, cloning and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells Characterization of the steroidogenic acute regulatory protein (StAR) J Biol Chem 269:28314-28322
20. Lin D, Sugawara T, Strauss JF III, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis Science 267:1828-1831
21. Arakane F, King SR, Du Y, Kallen CB, Walsh LP, Watari H, Stocco DM, Strauss JF III (1997) Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity J Biol Chem 272:32656-32662
22. Cherradi N, Rossier MF, Vallotton MB, Timberg R, Friedberg I, Orly J, Wang XJ, Stocco DM, Capponi AM (1997) Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome P450scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells J Biol Chem 272:7899-7907
23. Chung JY, Chen H, Midzak A, Burnett AL, Papadopoulos V, Zirkin BR (2013) Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged brown Norway rat leydig cells Endocrinology 154:2156-2165
24. Morohaku K, Pelton SH, Daugherty DJ, Ronald Butler W, Deng W, Selvaraj V (2014) Translocator protein/peripheral benzodiazepine receptor Is not required for steroid hormone biosynthesis Endocrinology 155:89-97
25. Banati RB, Middleton RJ, Chan R, Hatty CR, Wai- Ying Kam W, Quin C, Graeber MB, Parmar A, Zahra D, Callaghan P, Fok S, Howell NR, Gregoire M, Szabo A, Pham T, Davis E, Liu GJ (2014) Positron emission tomography and functional characterization of a complete PBR/TSPO knockout Nat Commun 5:5452
26. Miller WL, Bose HS (2011) Early steps in steroidogenesis: intracellular cholesterol trafficking. J Lipid Res 52:2111-2135
27. 5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer J Biol Chem 273:3158-3165
28. Lee TC, Miller WL, Auchus RJ (1999) Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes J Clin Endocrinol Metab 84:2104-2110
29. Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L (1998) Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol J Clin Endocrinol Metab 83:3996-4001
30. Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE (2006) Serum 21-deoxycortisol, 17-hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11β-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:2179-2184
31. Costa-Santos M, Kater CE, Auchus RJ (2004) Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 89:49-60
32. Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D (2004) Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia J Clin Endocrinol Metab 89:3687-3693
33. 5 expression during fetal development of the rhesus macaque Endocrinology 143:1451-1458
34. 5-4 isomerase (3β-HSD). J Clin Endocrinol Metab 84:3382-3385
35. Suzuki T, Sasano H, Takeyama J, Kaneko C, Freije WA, Carr BR, Rainey WE (2000) Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies Clin Endocrinol (Oxf) 53:739-747
36. 5 steroidogenic pathway J Clin Endocrinol Metab 88:3762-3766
37. Zhang L, Rodriguez H, Ohno S, Miller WL (1995) Serine phosphorylation of human P450c17 increases 17,20 lyase activity: implications for adrenarche and for the polycystic ovary syndrome Proc Natl Acad Sci U S A 92:10619-10623
38. 5 and by serine phosphorylation of P450c17 J Biol Chem 280:13265- 13271
39. Tee MK, Miller WL (2013) Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis J Biol Chem 288:23903-23913
40. Auchus RJ (2004) The backdoor pathway to dihydrotestosterone Trends Endocrinol Metab 15:432-438
41. Wilson JD, Auchus RJ, Leihy MW, Guryev OL, Estabrook RW, Osborn SM, Shaw G, Renfree MB (2003) 5α-androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate Endocrinology 144:575-580
42. 21 steroids are substrates for human cytochrome P450c17 Arch Biochem Biophys 418:151-160
43. Flück CE, Meyer-Boni M, Pandey AV, Kempna P, Miller WL, Schoenle EJ, Biason-Lauber A (2011) Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation Am J Hum Genet 89:201-218
44. Kamrath C, Hochberg Z, Hartmann MF, Remer T, Wudy SA, (2012) Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis J Clin Endocrinol Metab 97:E367-E375
45. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study Lancet 363:2128-2135
46. Homma K, Hasegawa T, Nagai T, Adachi M, Horikawa R, Fujiwara I, Tajima T, Takeda R, Fukami M, Ogata T (2006) Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone J Clin Endocrinol Metab 91:2643-2649
47. Sarda IR, Gorwill RH (1976) Hormonal studies in pregnancy: I Total unconjugated estrogens in maternal peripheral vein, cord vein, and cord artery serum at delivery Am J Obstet Gynecol 124:234-238
48. Saenger P, Klonari Z, Black SM, Compagnone N, Mellon SH, Fleischer A, Abrams CAL, Shackleton CHL, Miller WL (1995) Prenatal diagnosis of congenital lipoid adrenal hyperplasia J Clin Endocrinol Metab 80:200-205
49. Tuckey RC, Cameron KJ (1993) Catalytic properties of cytochrome P-450scc purified from the human placenta: comparison to bovine cytochrome P-450scc Arch Biochem Biophys 1163:185-194
50. Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW (2011) Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system Proc Natl Acad Sci U S A 108:10139-10143
51. 3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1) Proc Natl Acad Sci U S A 100:14754-14759
52. Slominski AT, Kim TK, Chen J, Nguyen MN, Li W, Yates CR, Sweatman T, Janjetovic Z, Tuckey RC (2012) Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes Int J Biochem Cell Biol 44:2003-2018
53. Slominski AT, Kim TK, Shehabi HZ, Semak I, Tang EK, Nguyen MN, Benson HA, Korik E, Janjetovic Z, Chen J, Yates CR, Postlethwaite A, Li W, Tuckey RC (2012) In vivo evidence for a novel pathway of vitamin D(3) metabolism initiated by P450scc and modified by CYP27B1. FASEB J 26:3901-3915
54. Davydov R, Gilep AA, Strushkevich NV, Usanov SA, Hoffman BM (2012) Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies J Am Chem Soc 134:17149-17156
55. Mast N, Annalora AJ, Lodowski DT, Palczewski K, Stout CD, Pikuleva IA (2011) Structural basis for three-step sequential catalysis by the cholesterol side-chain cleavage enzyme CYP11A1 J Biol Chem 286:5607-5613
56. Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D (1983) Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes J Clin Invest 71:1495-1499
57. Mast N, Linger M, Pikuleva IA (2013) Inhibition and stimulation of activity of purified recombinant CYP11A1 by therapeutic agents Mol Cell Endocrinol 371:100-106
58. Coghlan VM Vickery LE (1991) Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc J Biol Chem 266:18606-18612
59. Wada A, Waterman MR (1992) Identification by site-directed mutagenesis of two lysine residues in cholesterol side-chain cleavage cytochrome P450 that are essential for adrenodoxin binding J Biol Chem 267:22877-22882
60. Vickery LE (1997) Molecular recognition and electron transfer in mitochondrial steroid hydroxylase systems Steroids 62:124-127
61. Tajima T, Fujieda K, Kouda N, Nakae J, Miller WL (2001) Heterozygous mutation in the cholesterol side-chain cleavage enzyme (P450scc) gene in a patient with 46, XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86:3820-3825
62. Tee MK, Abramsohn M, Loewenthal N, Harris M, Siwach S, Kaplinsky A, Markus B, Birk O, Sheffield VC, Parvari R, Hershkovitz E, Miller WL (2013) Varied clinical presentations of seven patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc J Clin Endocrinol Metab 98:713-720
63. Gucev ZS, Tee MK, Chitayat D, Wherrett DK, Miller WL (2013) Distinguishing deficiencies in the steroidogenic acute regulatory protein and the cholesterol side-chain cleavage enzyme causing neonatal adrenal failure J Pediatr 162:819-822
64. Baker BY, Lin L, Kim CJ, Raza J, Smith CP, Miller WL, Achermann JC (2006) Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia J Clin Endocrinol Metab 91:4781-4785
65. White PC, Curnow KM, Pascoe L (1994) Disorders of steroid 11β-hydroxylase isozymes. Endocr Rev 15:421-438
66. Pascoe L, Curnow K, Slutsker L, Connel JMC, peiser PW, New MI, White PW (1992) Glucocorticoid- suppressible hyperaldosteronism results from hybrid genes created by unequal crossover between CYP11B1 and CYP11B2 Proc Natl Acad Sci U S A 89:8327-8331
67. Lifton R Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension Nature 335:262-265
68. Strushkevich N, Gilep AA, Shen L, Arrowsmith CH, Edwards AM, Usanov SA, Park HW (2013) Structural insights into aldosterone synthase substrate specificity and targeted inhibition. Mol Endocrinol 27:315-324
69. Pascoe L, Curnow K, Slutsker L, Rösler A, White PC (1992) Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methlyoxidase II deficiency. Proc Natl Acad Sci U S A 89:4996-5000
70. Portrat-Doyen S, Tourniaire J, Richard O, Mulatero P, Aupetit-Faisant B, Curnow KM, Pascoe L, Morel Y (1998) Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene J Clin Endocrinol Metab 83:4156-4161
71. Zhang G, Rodriguez H, Fardella CE, Harris DA, Miller WL (1995) Mutation T318M in P450c11AS causes corticosterone methyl oxidase II deficiency. Am J Hum Genet 57:1037-1043
72. Curnow KM, Tusie-Luna M, Pascoe L, Natarajan R, Gu J, Nadler JL, White PC (1991) The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex Mol Endocrinol 5:1513-1522
73. Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, Ohnishi T, Ichikawa Y, Nakao K, Imura H, Ulick S, Shizuta Y (1992) Role of steroid 11β-hydroxylase and 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans Proc Natl Acad Sci U S A 89:1458-1462
74. Ogishima T, Shibata H, Shimada H, Mitami F, Suzuki H, Saruta T, Ishimura Y (1991) Aldosterone synthase cytochrome P450 expressed in the adrenals of patients with primary aldosteronism J Biol Chem 266:10731-10734
75. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM (2000) High prevalence of primary aldosteronism in the Tayside hypertension clinic population J Hum Hypertens 14:311-315
76. Rossi GP, Seccia TM, Pessina AC (2008) Primary aldosteronism-part I: prevalence, screening, and selection of cases for adrenal vein sampling J Nephrol 21:447-454
77. Steele RE, Mellor LB, Sawyer WK, Wasvary JM, Browne LJ (1987) In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A Steroids 50:147-161
78. Fiebeler A, Nussberger J, Shagdarsuren E, Rong S, Hilfenhaus G, Al-Saadi N, Dechend R, Wellner M, Meiners S, Maser-Gluth C, Jeng AY, Webb R L, Luft FC, Muller DN (2005) Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage Circulation 111:3087-3094
79. LaSala D, Shibanaka Y, Jeng AY (2009) Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors Anal Biochem 394:56-61
80. Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L (1998) Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol J Clin Endocrinol Metab 83:3996-4001
81. Swart AC, Schloms L, Storbeck KH, Bloem LM, Toit T, Quanson JL, Rainey WE, Swart P (2013) 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione. J Steroid Biochem Mol Biol 138:132-142
82. White PC, Dupont J, New MI, Lieberman E, Hochberg Z, Rösler A (1991) A mutation in CYP11B1 (Arg 448→ His) associated with steroid 11β-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest 87:1664-1667
83. Kharrat M, Trabelsi S, Chaabouni M, Maazoul F, Kraoua L, Ben Jemaa L, Gandoura N, Barsaoui S, Morel Y, M'Rad R, Chaabouni H (2010) Only two mutations detected in 15 Tunisian patients with 11β-hydroxylase deficiency: the p.Q356X and the novel p G379V Clin Genet 78:398-401
84. Reisch N, Högler W, Parajes S, Rose IT, Dhir V, Gotzinger J, Arlt W, Krone N (2013) A diagnosis not to be missed: nonclassic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism J Clin Endocrinol Metab 98:E1620-1625
85. Liddle GW, Island D, Lance EM, Harris AP (1958) Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11β-hydroxylation. J Clin Endocrinol Metab 18:906- 912
86. Kenyon CJ, Young J, Gray CE, Fraser R (1984) Inhibition by etomidate of steroidogenesis in isolated bovine adrenal cells J Clin Endocrinol Metab 58:947-949
87. Schulte HM, Benker G, Reinwein D, Sippell WG, Allolio B (1990) Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects J Clin Endocrinol Metab 70:1426-1430
88. Andersen K, Hartman D, Peppard T, Hermann D, Van Ess P, Lefkowitz M, Trapani A (2012) The effects of aldosterone synthase inhibition on aldosterone and cortisol in patients with hypertension: a phase II, randomized, double-blind, placebo-controlled, multicenter study J Clin Hypertens 14:580-587
89. Bertagna X, Pivonello R, Fleseriu M, Zhang Y, Robinson P, Taylor A, Watson CE, Maldonado M, Hamrahian AH, Boscaro M, Biller BM (2014) LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study J Clin Endocrinol Metab 99:1375-1383
90. Escobar JC, Patel SS, Beshay VE, Suzuki T, Carr BR (2011) The human placenta expresses CYP17 and generates androgens de novo J Clin Endocrinol Metab 96:1385-1392
91. Hojo Y, Hattori TA, Enami T, Furukawa A, Suzuki K, Ishii HT, Mukai H, Morrison JH, Janssen WG, Kominami S, Harada N, Kimoto T, Kawato S (2004) Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017α and P450 aromatase localized in neurons Proc Natl Acad Sci U S A 101:865-870
92. Compagnone NA, Bulfone A, Rubenstein JLR, Mellon SH (1995) Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system Endocrinology 136:5212-5223
93. Dalla Valle L, Vianello S, Belvedere P, Colombo L (2002) Rat cytochrome P450c17 gene transcription is initiated at different start sites in extraglandular and glandular tissues J Steroid Biochem Mol Biol 82:377-384
94. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS (2008) Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration- resistant tumor growth Cancer Res 68:4447- 4454
95. Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM, Bremner WJ, Gleave ME, Nelson PS (2007) Intraprostatic androgens and androgenregulated gene expression persist after testosterone suppression: therapeutic implications for castrationresistant prostate cancer Cancer Res 67:5033-5041
96. Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI (1993) Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase. J Clin Endocrinol Metab 77:98- 102
97. Swart AC, Storbeck KH, Swart P (2010) A single amino acid residue, Ala 105, confers 16α-hydroxylase activity to human cytochrome P450 17α-hydroxylase/17,20 lyase. J Steroid Biochem Mol Biol 119:112-120
98. Yoshimoto FK, Zhou Y, Peng HM, Stidd D, Yoshimoto JA, Sharma KK, Matthew S, Auchus RJ (2012) Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates Biochemistry 51:7064-7077
99. 5-steroid-17,20- lyase reactions Mol Endocrinol 3:968-975
100. 5-lyase activity of rat CYP17 J Biol Chem 268:18267-18271
101. Yang WH, Lutz LB, Hammes SR (2003) Xenopus laevis ovarian CYP17 is a highly potent enzyme expressed exclusively in oocytes Evidence that oocytes play a critical role in Xenopus ovarian androgen production J Biol Chem 278:9552-9559
102. 21-steroid biosynthesis in the fish ovary and head kidney Endocrinology 148:4282- 4291
103. 17α (17α-hydroxylase-17,20- lyase) J Chem Soc Perkin Trans I:263-267
104. Auchus RJ, Miller WL (1999) Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations Mol Endocrinol 13:1169-1182
105. 5 in the biosynthesis of androgens by human P450c17 Arch Biochem Biophys 317:343-347
106. 5 gene causes 46, XY disorder of sex development due to true isolated 17,20 lyase deficiency J Clin Endocrinol Metab 97:E465-E475
107. 5 mutation W27X J Clin Endocrinol Metab 95:994-999
108. 5 Biochem J 332:293-296
109. 5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions Biochemistry 40:5018-5031
110. 5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17 Biochemistry 45:755-762
111. 5 interactions revealed by NMR J Biol Chem 288:17008-17018
112. 5 on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65 Biochemistry 52:210-220
113. 21 side-chain cleavage from pig testis Biochem Biophys Res Commun 132:708-713
114. 5: endocrinological and mechanistic implications Biochem J 308:901-908
115. Akhtar M, Corina D, Miller S, Shyadehi AZ, Wright JN (1994) Mechanism of the acyl-carbon cleavage and related reactions catalyzed by multifunctional P- 450s: studies on cytochrome P-450(17α). Biochemistry 33:4410-4418
116. Akhtar M, Wright JN, Lee-Robichaud P (2011) A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17). J Steroid Biochem Mol Biol 125:2-12
117. 17α; 17α-hydroxylase-17,20-lyase). Biochemistry 34:14104-14113
118. 5-dependent acyl-carbon cleavage activities J Steroid Biochem Mol Biol 92:119-130
119. Billen MJ, Squires EJ (2009) The role of porcine cytochrome b5A and cytochrome b5B in the regulation of cytochrome P45017A1 activities J Steroid Biochem Mol Biol 113:98-104
120. Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene encoding P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity to the gene for P450c21 DNA 6:439-448
121. Geller DH, Auchus RJ, Mendonça BB, Miller WL (1997) The genetic and functional basis of isolated 17,20 lyase deficiency Nature Genet 17:201-205
122. Van Den Akker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, Timmerman MA, Otten BJ, Drop SL, De Jong FH (2002) Differential inhibition of 17α-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency J Clin Endocrinol Metab 87:5714-5721
123. Sherbet DP, Tiosano D, Kwist KM, Hochberg Z, Auchus RJ (2003) CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding J Biol Chem 278:48563-48569
124. Hershkovitz E, Parvari R, Wudy SA, Hartmann MF, Gomes LG, Loewental N, Miller WL (2008) Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency J Clin Endocrinol Metab 93:3584-3588
125. ten Kate-Booij MJ, Cobbaert C, Koper JW, de Jong FH (2004) Deficiency of 17,20-lyase causing giant ovarian cysts in a girl and a female phenotype in her 46, XY sister: case report Hum Reprod 19:456-459
126. Pandey AV, Mellon SH, Miller WL (2003) Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17 J Biol Chem 278:2837-2844
127. 17,20-lyase): potential agents for the treatment of prostatic cancer J Med Chem 38:2463-2471
128. de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Flechon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI (2011) Abiraterone and increased survival in metastatic prostate cancer N Engl J Med 364:1995-2005
129. Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE (2013) Abiraterone in metastatic prostate cancer without previous chemotherapy N Engl J Med 368:138-148
130. Garrido M, Peng HM, Yoshimoto FK, Upadhyay SK, Bratoeff E, Auchus RJ (2014) A-Ring modified steroidal azoles retain similar potent and slowly reversible CYP17A1 inhibition as abiraterone J Steroid Biochem Mol Biol 143:1-10
131. Handratta VD, Vasaitis TS, Njar VC, Gediya LK, Kataria R, Chopra P, Newman D Jr, Farquhar R, Guo Z, Qiu Y, Brodie AM (2005) Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model J Med Chem 48:2972-2984
132. Kaku T, Hitaka T, Ojida A, Matsunaga N, Adachi M, Tanaka T, Hara T, Yamaoka M, Kusaka M, Okuda T, Asahi S, Furuya S, Tasaka A (2011) Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer Bioorg Med Chem 19:6383-6399
133. Yin L, Hu Q (2014) CYP17 inhibitors-abiraterone, C17,20-lyase inhibitors and multi-targeting agents Nat Rev Urol 11:32-42
134. DeVore NM, Scott EE (2012) Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 Nature 482:116-119
135. Auchus RJ, Kumar AS, Boswell CA, Gupta MK, Bruce K, Rath NP, Covey DF (2003) The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 P450c21 Arch Biochem Biophys 409:134-144
136. Mizrachi D, Wang Z, Sharma KK, Gupta MK, Xu K, Dwyer CR, Auchus RJ (2011) Why human cytochrome P450c21 is a progesterone 21-hydroxylase Biochemistry 50:3968-3974
137. Zhao B, Lei L, Kagawa N, Sundaramoorthy M, Banerjee S, Nagy LD, Guengerich FP, Waterman MR (2012) A three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants J Biol Chem 287:10613-10622
138. Yoshimoto FK, Desilets MC, Auchus RJ (2012) Synthesis of halogenated pregnanes, mechanistic probes of steroid hydroxylases CYP17A1 and CYP21A2 J Steroid Biochem Mol Biol 128:38-50
139. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii- Kuriyama Y (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and genuine gene Proc Natl Acad Sci U S A 83:2841- 2845
140. White PC, New MI, Dupont B (1986) Structure of the human steroid 21-hydroxylase genes Proc Natl Acad Sci U S A 83:5111-5115
141. White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Endocr Rev 21:245-291
142. Therrell BLJ, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1 9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia Pediatrics 101:583-590
143. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency Am J Hum Genet 37:650-667
144. Speiser PW, Knochenhauer ES, Dewailly D, Fruzzetti F, Marcondes JA, Azziz R (2000) A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype Mol Genet Metab 71:527-534
145. Wright JN, Akhtar M (1990) Studies on estrogen biosynthesis using radioactive and stable isotopes Steroids 55:142-151
146. Thompson EA Jr, Siiteri PK (1974) Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione J Biol Chem 249:5364-5372
147. Fishman J, Raju MS (1981) Mechanism of estrogen biosynthesis Stereochemistry of C-1 hydrogen elimination in the aromatization of 2β-hydroxy-19- oxoandrostenedione J Biol Chem 256:4472-4477
148. 2H]androgens into oestrogens by human placental aromatase An unexpected stereochemical outcome Biochem J 268:553-561
149. Akhtar M, Calder MR, Corina DL, Wright JN (1982) Mechanistic studies on C-19 demethylation in oestrogen biosynthesis Biochem J 201:569-580
150. Beusen DD, Carrell HL, Covey DF (1987) Metabolism of 19-methyl-substituted steroids by human placental aromatase Biochemistry 26:7833-7841
151. 18O]androstenedione by human placental aromatase J Steroid Biochem 20:931-934
152. Goto J, Fishman J (1977) Participation of a nonenzymatic transformation in the biosynthesis of estrogens from androgens Science 195:80-81
153. Sohl CD, Guengerich FP (2010) Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1 J Biol Chem 285:17734- 17743
154. Cole PA, Robinson CH (1991) Mechanistic studies on a placental aromatase model reaction J Am Chem Soc 113:8130-8137
155. Sen K, Hackett JC (2012) Coupled electron transfer and proton hopping in the final step of CYP19- catalyzed androgen aromatization Biochemistry 51:3039-3049
156. Covey DF, Carrell HL, Beusen DD (1987) Metabolism of 19-methyl substituted steroids and a proposal for the third aromatase monooxygenation Steroids 50:363-374
157. Hackett JC, Brueggemeier RW, Hadad CM (2005) The final catalytic step of cytochrome P450 aromatase: a density functional theory study J Am Chem Soc 127:5224-5237
158. Covey DF, Hood WF, Parikh VD (1981) 10β-Propynyl-substituted steroids. Mechanismbased enzyme-activated irreversible inhibitors of estrogen biosynthesis J Biol Chem 256:1076-1079
159. Covey DF, Hood WF (1982) Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy- 4-androstene-3,17-dione Mol Pharmacol 21:173-180
160. Covey DF, Hood WF (1981) Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a timedependent decrease in human placental aromatase activity Endocrinology 108:1597-1599
161. Bhatnagar AS, Hausler A, Schieweck K, Lang M, Bowman R (1990) Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor J Steroid Biochem Mol Biol 37:1021-1027
162. Plourde PV, Dyroff M, Dukes M (1994) Arimidex: a potent and selective fourth-generation aromatase inhibitor Breast Cancer Res Treat 30:103-111
163. Auchus ML, Auchus RJ (2012) Human steroid biosynthesis for the oncologist J Investig Med 60:495- 503
164. Ghosh D, Griswold J, Erman M, Pangborn W (2009) Structural basis for androgen specificity and oestrogen synthesis in human aromatase Nature 457:219- 223
165. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD et al (1994) Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocr Rev 15:342- 355
166. Roselli CE, Liu M, Hurn PD (2009) Brain aromatization: classic roles and new perspectives Semin Reprod Med 27:207-217
167. Chortis V, Taylor AE, Schneider P, Tomlinson JW, Hughes BA, O'Neil DM, Libe R, Allolio B, Bertagna X, Bertherat J, Beuschlein F, Fassnacht M, Karavitaki N, Mannelli M, Mantero F, Opocher G, Porfiri E, Quinkler M, Sherlock M, Terzolo M, Nightingale P, Shackleton CH, Stewart PM, Hahner S, Arlt W (2013) Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement J Clin Endocrinol Metab 98:161-171
168. Mannel M (2004) Drug interactions with St John's wort: mechanisms and clinical implications Drug Saf 27:773-797
169. Zhou S, Chan E, Pan SQ, Huang M, Lee EJ (2004) Pharmacokinetic interactions of drugs with St John's wort J Psychopharmacol 18:262-276
170. Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC (2003) The interaction between St John's wort and an oral contraceptive Clin Pharmacol Therap 74:525-535
171. Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J (2003) Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial Br J Clin Pharmacol 56:683-690
172. Porter FD, Herman GE (2011) Malformation syndromes caused by disorders of cholesterol synthesis J Lipid Res 52:6-34
173. Wassif CA, Zhu P, Kratz L, Krakowiak PA, Battaile KP, Weight FF, Grinberg A, Steiner RD, Nwokoro NA, Kelley RI, Stewart RR, Porter FD (2001) Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome Hum Mol Genet 10:555-564
174. Norman AW (1998) Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system Am J Clin Nutr 67:1108-1110
175. 3: gonadotropic regulation of the cognate mRNA in ovaries DNA Cell Biol 9:657-665
176. 3 25-hydroxylase from rat liver mitochondria FEBS Lett 262:135-138
177. Cali JJ, Russell DW (1991) Characterization of human sterol 27-hydroxylase A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis J Biol Chem 266:7774-7778
178. Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz SP, Dann EJ, Berkman N, Cali JJ, Klapholz L, Berginer VM (1993) Frameshift and splicejunction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews of Moroccan origin J Clin Invest 91:2488-2496
179. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW (2003) De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase J Biol Chem 278:38084-38093
180. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW (2004) Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase Proc Natl Acad Sci U S A 101:7711-7715
181. Bieche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues Pharmacogenet Genomics 17:731-742
182. 3 J Mol Biol 380:95-106
183. 3 by cultured pulmonary alveolar macrophages in sarcoidosis J Clin Invest 72:1856-1860
184. 3 J Biol Chem 256:7738-7740
185. 3 production by human keratinocytes J Clin Invest 78:557-566
186. Fu GK, Lin D, Zhang MYH, Bikle DD, Shackleton CHL, Miller WL, Portale AA (1997) Cloning of human 25-hydroxy vitamin D-1α-hydroxylase and mutations causing vitamin D-dependant rickets type I Mol Endocrinol 11:1961-1970
187. 3 1α-hydroxylase. Biochem Biophys Res Commun 239:527-533
188. 3- 1α-hydroxylase cDNA. Proc Natl Acad Sci U S A 94:12920-12925
189. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH (1997) The 25-hydroxyvitamin D 1α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus J Bone Miner Res 12:1552-1559
190. 3 1α-hydroxylase and vitamin D synthesis. Science 277:1827-1830
191. Fu GK, Portale AA, Miller WL (1997) Complete structure of the human gene for the vitamin D 1α-hydroxyase, P450c1α. DNA Cell Biol 16:1499- 1507
192. 3 Biochemistry 25:1545- 1548
193. De Braekeleer M, Larochelle J (1991) Population genetics of vitamin D-dependent rickets in northeastern Quebec Ann Hum Genet 55:283-290
194. Labuda M, Morgan K, Glorieux FH (1990) Mapping autosomal recessive vitamin D dependency type 1 to chromosomal 12q14 by linkage analysis Am J Hum Genet 47:28-36
195. 3 1α-hydroxylase gene in patients with pseudovitamin D-deficiency rickets N Engl J Med 338:653-661
196. Smith SJ, Rucka AK, Berry JL, Davies M, Mylchreest S, Paterson CR, Heath DA, Tassagehji M, Read AP, Mee AP, Mawer EB (1999) Novel mutations in the 1α-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages J Bone Mineral Res 14:730-739
197. Wang JT, Lin CJ, Burridge SM, Fu GK, Labuda M, Portale AA, Miller WL (1998) Genetics of vitamin D 1α-hydroxylase deficiency in 17 families. Am J Hum Genet 63:1694-1702
198. Yoshida T, Monkawa T, Tenenhouse H, Goodyer P, Shinki T, Suda T, Wakino S, Hayashi M, Saruta T (1998) Two novel 1α-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I Kidney Int 54:1437-1443
199. Alzahrani AS, Zou M, Baitei EY, Alshaikh OM, Al- Rijjal RA, Meyer BF, Shi Y (2010) A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1 J Clin Endocrinol Metab 95:4176-4183
200. Edouard T, Alos N, Chabot G, Roughley P, Glorieux FH, Rauch F (2011) Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol J Clin Endocrinol Metab 96:82-89
201. Kim CJ, Kaplan LE, Perwad F, Huang N, Sharma A, Choi Y, Miller WL, Portale AA (2007) Vitamin D 1α-hydroxylase gene mutations in patients with 1α-hydroxylase deficiency. J Clin Endocrinol Metab 92:3177-3182
202. Wang X, Zhang MY, Miller WL, Portale AA (2002) Novel gene mutations in patients with 1α-hydroxylase deficiency that confer partial enzyme activity in vitro J Clin Endocrinol Metab 87:2424-2430
203. 3 24-hydroxylase cDNA Proc Natl Acad Sci U S A 90:4543-4547
204. 3 24-hydroxylase FEBS Lett 278:195-198
205. 3-24-hydroxylase gene promoter and identification of two vitamin D-responsive elements Biochim Biophys Acta 1263:1-9
206. 3 autoregulation in keratinocytes J Biol Chem 277:36987-36990
207. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz- Broking E, Fehrenbach H, Wingen AM, Guran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia N Engl J Med 365:410-421
208. Dauber A, Nguyen T, ohett E, Cole DE, Horst R, Abrams SA, Carpenter TO, Hirschhorn JN (2012) Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia J Clin Endocrinol Metab 97:E268-274
209. Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, Foreman JW, Chelminski PR, Kumar R (2012) Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy J Clin Endocrinol Metab 97:E423-427
210. Annalora AJ, Goodin DB, Hong WX, Zhang Q, Johnson EF, Stout CD (2010) Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism J Mol Biol 396:441-451